Oncolytic Immunotherapy for Treatment of Breast Cancer, Including Triple-Negative Breast Cancer

被引：0
|
作者：
Bramante, Simona [1 ,2 ]
Koski, Anniina [1 ,2 ]
Liikanen, Ilkka [1 ,2 ]
Oksanen, Minna [1 ,2 ]
Joensuu, Timo [3 ]
Pesonen, Sari [1 ,2 ]
Hemminki, Akseli [1 ,2 ]
机构：
[1] Univ Helsinki, Canc Gene Therapy Grp, Dept Pathol & Transplantat Lab, Helsinki, Finland
[2] Univ Helsinki, Haartman Inst, Helsinki, Finland
[3] Docrates Canc Ctr, Helsinki, Finland
来源：
MOLECULAR THERAPY | 2015年 / 23卷
关键词：
D O I：
10.1016/S1525-0016(16)34047-3
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
438
引用
收藏
页码：S173 / S173
页数：1
相关论文
共 50 条
  • [21] Immunotherapy in Combination with Chemotherapy for Triple-negative Breast Cancer
    Elizabeth, Melendez Solano
    Cristina, Stevens Barron Jazmin
    Christian, Chapa Gonzalez
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2024, 24 (04) : 431 - 439
  • [22] Immunotherapy in Triple-Negative Breast Cancer: Present and Future
    Kim, Isaac
    Sanchez, Katherine
    McArthur, Heather L.
    Page, David
    [J]. CURRENT BREAST CANCER REPORTS, 2019, 11 (04) : 259 - 271
  • [23] Progress and challenges of immunotherapy in triple-negative breast cancer
    Zhu, Yinxing
    Zhu, Xuedan
    Tang, Cuiju
    Guan, Xiaoxiang
    Zhang, Wenwen
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1876 (02):
  • [24] The clinical promise of immunotherapy in triple-negative breast cancer
    Vikas, Praveen
    Borcherding, Nicholas
    Zhang, Weizhou
    [J]. CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 6823 - 6833
  • [25] The epidemiology of triple-negative breast cancer, including race
    Katrina F. Trivers
    Mary Jo Lund
    Peggy L. Porter
    Jonathan M. Liff
    Elaine W. Flagg
    Ralph J. Coates
    J. William Eley
    [J]. Cancer Causes & Control, 2009, 20 : 1071 - 1082
  • [26] The epidemiology of triple-negative breast cancer, including race
    Trivers, Katrina F.
    Lund, Mary Jo
    Porter, Peggy L.
    Liff, Jonathan M.
    Flagg, Elaine W.
    Coates, Ralph J.
    Eley, J. William
    [J]. CANCER CAUSES & CONTROL, 2009, 20 (07) : 1071 - 1082
  • [27] Immunotherapy Treatment for Triple Negative Breast Cancer
    Berger, Elizabeth R.
    Park, Tristen
    Saridakis, Angeleke
    Golshan, Mehra
    Greenup, Rachel A.
    Ahuja, Nita
    [J]. PHARMACEUTICALS, 2021, 14 (08)
  • [28] Novel chimeric parapoxvirus CF189 as an oncolytic immunotherapy in triple-negative breast cancer
    Choi, Audrey H.
    O'Leary, Michael P.
    Chaurasiya, Shyambabu
    Lu, Jianming
    Kim, Sang-In
    Fong, Yuman
    Chen, Nanhai G.
    [J]. SURGERY, 2018, 163 (02) : 336 - 342
  • [29] Nanomedicine for the treatment of triple-negative breast cancer
    Kutty, Rajaletchumy Veloo
    Leong, David Tai Wei
    Feng, Si-Shen
    [J]. NANOMEDICINE, 2014, 9 (05) : 561 - 564
  • [30] Targeted Treatment of Triple-Negative Breast Cancer
    Young, Joanna A.
    Tan, Antoinette R.
    [J]. CANCER JOURNAL, 2021, 27 (01): : 50 - 58
12345